The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity Against the Human Malaria Parasite Plasmodium falciparum via Polypharmacological Inhibition of PfArk1 and Hemozoin Formation
Kathryn J. Wicht, John G. Woodland, Larnelle F. Garnie, Henrico Langeveld, Dale Taylor, Luiz Claudio Godoy, Charisse Flerida A. Pasaje, Mariana Laureano de Souza, Jair L. Siqueira-Neto, Sonja Ghidelli, María José Lafuente-Monasterio, Francisco‐Javier Gamo, Dina Coertzen, Janette Reader, Mariëtte van der Watt, , Kelly Chibale
This study shows that CHIR-124, a human Chk1 inhibitor, is active against Plasmodium falciparum through dual inhibition of PfArk1 and hemozoin formation, suggesting polypharmacology as a strategy for antimalarial drugs.
ACS Chemical Biology · Jun 13, 2026Peer-reviewedMicrobiology